2006•European Journal of CancerRequires access

The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review

Ferry A.L.M. Eskens, Jaap Verweij

Open publisher page 343 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 343 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Vascular endothelial growth factor, Angiogenesis, Kinase insert domain receptor, Vascular endothelial growth factor C, Vascular endothelial growth factor B, Vascular endothelial growth factor A, Cancer research, Tyrosine kinase

Back to paper search Browse research topics Original source

The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review — Research Paper | ScholarLens